title: Leukocytoclastic vasculitis following lenalidomide during the treatment of follicular lymphoma.
authors.affiliation: a Division of Medical Oncology , BC Cancer Agency , Vancouver , Canada.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Loree
authors.affiliation: b Department of Pathology and Laboratory Medicine , University of British Columbia , Vancouver , Canada.
authors.forename: Ellen
authors.initials: E
authors.lastname: Cai
authors.affiliation: b Department of Pathology and Laboratory Medicine , University of British Columbia , Vancouver , Canada.
authors.forename: Brandon S
authors.initials: BS
authors.lastname: Sheffield
authors.affiliation: c Department of Dermatology and Skin Science , University of British Columbia , Vancouver , Canada.
authors.forename: Jan P
authors.initials: JP
authors.lastname: Dutz
authors.affiliation: a Division of Medical Oncology , BC Cancer Agency , Vancouver , Canada.
authors.forename: Diego
authors.initials: D
authors.lastname: Villa
authors.affiliation: d Department of Pathology and Molecular Medicine , Queen's University , Kingston , Ontario , Canada.
authors.forename: Lois E
authors.initials: LE
authors.lastname: Shepherd
authors.affiliation: a Division of Medical Oncology , BC Cancer Agency , Vancouver , Canada.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Connors
authors.affiliation: a Division of Medical Oncology , BC Cancer Agency , Vancouver , Canada.
authors.forename: Laurie H
authors.initials: LH
authors.lastname: Sehn
authors.affiliation: a Division of Medical Oncology , BC Cancer Agency , Vancouver , Canada.
authors.forename: Kerry J
authors.initials: KJ
authors.lastname: Savage
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D000077269:Lenalidomide; D008224:Lymphoma, Follicular / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008875:Middle Aged; D012867:Skin / Q000473:pathology; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000175:diagnosis* / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide